contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment CompanyTagList on Company {
  pageUrl
  name
  viewerIsFollowing
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    ...CompanyTagList
    id
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      defaultInstrument {
        isin
        id
      }
      id
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    id
    name
    viewerIsFollowing
    defaultInstrument {
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


vimian-group-ab-publ-publishes-prospectus-in-connection-with-its-listing-on-nasdaq-stockholms-main-market

__typename

title

isPremium

lang

htmlBody

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

Vimian Group is a group active in animal health. Through its subsidiaries, the company delivers medicines and technical solutions to veterinarians, laboratories, and pet owners. The products include, for example, drugs with associated clinical research and digital platforms for veterinary clinics. The company operates worldwide and is headquartered in Stockholm. 

Vimian Group

Vimian Group AB (publ) (”Vimian” or the ”Company”) announced on 14 March 2025 that Nasdaq Stockholm’s listing committee had approved Vimian’s application to admit the Company’s ordinary shares...

<div class="mfn-preamble"><p><strong>Vimian Group AB (publ) (”Vimian” or the ”Company”) announced on 14 March 2025 that Nasdaq Stockholm’s listing committee had approved Vimian’s application to admit the Company’s ordinary shares to trading on Nasdaq Stockholm’s Main Market. The prospectus that has been prepared in connection with the uplisting has today been approved and registered by the Swedish Financial Supervisory Authority (the “SFSA”) and is now available on Vimian’s website, www.vimian.com, and on the SFSA’s website, www.fi.se.</strong></p></div><div class="mfn-body"><p>The first day of trading on Nasdaq Stockholm is expected to be Friday, 28 March 2025 and the last day of trading on Nasdaq First North Growth Market is expected to be Thursday, 27 March 2025. Vimian’s ordinary shares will be traded in the Large Cap segment with unchanged ticker (VIMIAN) and unchanged ISIN code (SE0015961982). There will be no offer or issuance of new shares in connection with the change of marketplace to Nasdaq Stockholm and shareholders in Vimian do not need to take any action in connection therewith.</p><p>Advokatfirman Vinge is acting as legal advisor to Vimian in connection with the listing on Nasdaq Stockholm.</p></div><div class="mfn-footer mfn-contacts mfn-ddfb1f46825b"><p><strong class="mfn-heading-1">For further information, please contact:</strong></p><hr><p><strong>Maria Dahllöf Tullberg</strong><br>Head of IR, Communications &amp; Sustainability<br><a rel="noopener" href="mailto:maria.tullberg@vimian.com">maria.tullberg@vimian.com</a><br>+46 736 26 88 86</p></div><div class="mfn-footer mfn-about mfn-b6e2606a1fc5"><p><strong class="mfn-heading-1">About Vimian</strong></p><hr><p>Vimian is a global animal health company covering four essential and rapidly evolving areas: Specialty Pharma, MedTech, Veterinary Services and Diagnostics. At Vimian, we believe that every animal deserves the best available care. We bring pioneering and entrepreneurial businesses together to make the market’s most innovative offerings accessible to more animal health professionals and pet owners. Headquartered in Stockholm, Sweden, Vimian reaches over 17,000 veterinary clinics and laboratories, sells to over 80 markets, has 1,200 employees and annual revenues of approximately EUR 375 million. For more information, please visit: <a rel="noopener" href="http://www.vimian.com.">www.vimian.com.</a> FNCA Sweden AB is appointed the Company’s Certified Adviser.</p></div><div class="mfn-footer mfn-attachment mfn-attachment-general"><p><strong class="mfn-heading-1">Attachments</strong></p><hr><p><a rel="noopener" href="https://storage.mfn.se/04f72295-9c72-4b51-8308-1facf4ae3bb9/vimian-group-ab-publ-publishes-prospectus-in-connection-with-its-listing-on-nasdaq-stockholms-main-market.pdf" class="mfn-generated mfn-primary">Vimian Group AB (publ) publishes prospectus in connection with its listing on Nasdaq Stockholm’s Main Market</a><br><a rel="noopener" href="https://storage.mfn.se/b2a42220-ab98-4dcd-92c8-b681fe1e3175/vimian-prospectus.pdf">Vimian Prospectus</a></p></div>

Vimian Group AB (publ) publishes prospectus in connection with its listing on Nasdaq Stockholm’s Main Market